Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariella G Filbin

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Acta Neuropathologica Communications|July 16, 2020
Molecular and clinicopathologic features of gliomas harboring NTRK fusionsMatthew Torre, Varshini Vasudevaraja, Jonathan Serrano, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Serotonergic neuron-glioma interactions drive high-grade glioma pathophysiologyRichard Drexler, Belgin Yalçın, Rebecca Mancusi, et al.
Oncoimmunology|October 3, 2022
Immunotherapy approaches for the treatment of diffuse midline gliomasJoshua D Bernstock, Samantha E Hoffman, Ari D Kappel, et al.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Cancer Cell|October 22, 2019
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPGJamie N Anastas, Barry M Zee, Jay H Kalin, et al.
Nature Neuroscience|December 3, 2024
Applying single-cell and single-nucleus genomics to studies of cellular heterogeneity and cell fate transitions in the nervous systemIgor Adameyko, Trygve Bakken, Aparna Bhaduri, et al.
Neuro-Oncology|September 13, 2023
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signalingMarco Bruschi, Lilia Midjek, Yassine Ajlil, et al.
Neuro-Oncology|June 26, 2026
Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-gliomaAndrew Groves, Orville O Kirkland, Costanza Lo Cascio, et al.
Cancer Cell|August 19, 2022
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline gliomaSharmistha Pal, Jakub P Kaplan, Huy Nguyen, et al.
Neuro-Oncology|February 14, 2022
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomasJustyna M Przystal, Chiara Cianciolo Cosentino, Sridevi Yadavilli, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Acta Neuropathologica Communications|July 16, 2020
Molecular and clinicopathologic features of gliomas harboring NTRK fusionsMatthew Torre, Varshini Vasudevaraja, Jonathan Serrano, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
Serotonergic neuron-glioma interactions drive high-grade glioma pathophysiologyRichard Drexler, Belgin Yalçın, Rebecca Mancusi, et al.
Oncoimmunology|October 3, 2022
Immunotherapy approaches for the treatment of diffuse midline gliomasJoshua D Bernstock, Samantha E Hoffman, Ari D Kappel, et al.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Cancer Cell|October 22, 2019
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPGJamie N Anastas, Barry M Zee, Jay H Kalin, et al.
Nature Neuroscience|December 3, 2024
Applying single-cell and single-nucleus genomics to studies of cellular heterogeneity and cell fate transitions in the nervous systemIgor Adameyko, Trygve Bakken, Aparna Bhaduri, et al.
Neuro-Oncology|September 13, 2023
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signalingMarco Bruschi, Lilia Midjek, Yassine Ajlil, et al.
Neuro-Oncology|June 26, 2026
Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-gliomaAndrew Groves, Orville O Kirkland, Costanza Lo Cascio, et al.
Cancer Cell|August 19, 2022
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline gliomaSharmistha Pal, Jakub P Kaplan, Huy Nguyen, et al.
Neuro-Oncology|February 14, 2022
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomasJustyna M Przystal, Chiara Cianciolo Cosentino, Sridevi Yadavilli, et al.
Pageof 8